Surprisingly, the dexamethasone (glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant) (frequency = 5, top ranked) in our prediction, see Table 3), an existing FDA approved drug, was recently reported to be the first drug that can significantly reduce the death rate of COVID-19 patients receiving respiratory support [5]. The gene discussed is NR3C1; the disease is COVID-19.